רווח נקי למניה (EPS TTM): Journey Medical Corp. (DERM)

Journey Medical (DERM) TTM net income per share on GURU.Markets contains data where the impact of geopolitical risks and raw material supply disruptions is compared with the trend, and -0.19 expresses the current value of the metric. Profit stability is based on physician trust in approved brands, while the operating balance is maintained through marketing control during the expansion of the sales network.

Journey Medical is expanding its presence in pharmacy retail, leveraging a strong talent pool of dermatologists and efficient recruitment of sales representatives. By analyzing the rolling earnings per share trend, an investor can see the annual net income distributed across the total share issuance, which allows for an objective assessment of the business's operational resilience and the fundamental support for the current market value of the securities.